← Open Payments lookup

CARLOS VELAS: Open Payments

NPI 1447390455 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,236 in 202 payments from 11 companies in 2025. Trend: 2023 $1,852 · 2024 $2,404 · 2025 $3,236

Food & beverage: $3,126Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.50$642
Neurocrine BioSciences, Inc.31$564
Janssen Pharmaceuticals, Inc22$345
E.R. Squibb & Sons, L.L.C.14$338
Alkermes, Inc.16$333
Otsuka America Pharmaceutical, Inc.13$237
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$217
ABBVIE INC.21$212
Vanda Pharmaceuticals Inc.8$139
Lundbeck LLC15$135

Products named: INGREZZA, UZEDY, COBENFY, ARISTADA, REXULTI, INVEGA SUSTENNA, CAPLYTA, VRAYLAR.

Industry payments across PA — which companies pay providers there.